T1	Methodology 51 112	randomized, double-blind, placebo-controlled, crossover trial
T2	Population 116 130	healthy adults
T3	Nutrient 10 25	arabinogalactan
T4	Nutrient 201 216	arabinogalactan
T5	Nutrient 263 290	non-digestible carbohydrate
T6	AFFECTS 401 407	effect
T7	Nutrient 414 429	arabinogalactan
T8	Metabolite 478 501	short-chain fatty acids
T9	Physiology 506 532	gastrointestinal tolerance
T10	Population 536 550	healthy adults
T11	Methodology 556 597	randomized, double-blind, crossover trial
T12	Nutrient 689 698	ResistAid
T13	Nutrient 439 448	ResistAid
T14	Nutrient 663 675	maltodextrin
T15	Nutrient 750 759	ResistAid
T16	INCREASES 870 878	increase
T17	DiversityMetric 813 855	ratio of fecal Firmicutes to Bacteroidetes
T18	DECREASES 797 805	decrease
T19	Microorganism 882 895	Bacteroidetes
T20	DECREASES 902 910	decrease
T21	Microorganism 914 924	Firmicutes
T22	Microorganism 962 977	Bifidobacterium
T23	INCREASES 988 996	increase
T24	Nutrient 1002 1011	ResistAid
T25	Nutrient 1043 1052	ResistAid
T26	DECREASES 1067 1076	decreased
T27	DiversityMetric 1081 1092	α-diversity
T28	Methodology 1159 1177	16S rRNA sequences
T29	Nutrient 1190 1199	ResistAid
T30	INCREASES 1216 1225	increased
T31	Nutrient 1464 1473	ResistAid
T32	Methodology 1118 1149	Predicted functional abundances
T33	Enzyme 1271 1287	α-l-rhamnosidase
T34	Enzyme 1289 1303	β-fructosidase
T35	Enzyme 1309 1317	levanase
T36	Physiology 1330 1348;1364 1385	tricarboxylic acid biosynthesis pathways
T37	Physiology 1353 1385	vitamin B6 biosynthesis pathways
T38	Metabolite 1418 1432	hexanoic acids
T39	Metabolite 1405 1412;1427 1432	valeric acids
T40	Metabolite 1393 1403;1427 1432	isovaleric acids
T41	DECREASES 1452 1457	lower
T42	Physiology 1538 1549	bowel habit
T43	Physiology 1551 1568	stool consistency
T44	Physiology 1570 1605	gastrointestinal tolerance symptoms
T45	Nutrient 1696 1705	ResistAid
T46	AFFECTS 1501 1534	statistically significant changes
T47	Nutrient 1843 1852	ResistAid
E1	AFFECTS:T6 Theme:T8 Agent:T13
E2	INCREASES:T16 Agent:T15 Theme:T19
E3	DECREASES:T18 Agent:T15 Theme:T17
E4	DECREASES:T20 Agent:T15 Theme:T21
E5	INCREASES:T23 Agent:T24 Theme:T22
E6	DECREASES:T26 Theme:T27 Agent:T25
E7	INCREASES:T30 Agent:T29 Theme:T33
E8	AFFECTS:T6 Theme:T9 Agent:T13
E9	INCREASES:T30 Agent:T29 Theme:T34
E10	INCREASES:T30 Agent:T29 Theme:T35
E11	INCREASES:T30 Agent:T29 Theme:T36
E12	INCREASES:T30 Agent:T29 Theme:T37
E13	DECREASES:T41 Agent:T31 Theme:T40
E14	DECREASES:T41 Agent:T31 Theme:T39
E15	DECREASES:T41 Agent:T31 Theme:T38
E16	AFFECTS:T46 Theme:T42 Agent:T45
E17	AFFECTS:T46 Theme:T43 Agent:T45
E18	AFFECTS:T46 Theme:T44 Agent:T45
A1	Unknown E8
A2	Unknown E1
A3	Negated E16
A4	Negated E17
A5	Negated E18
N1	CHEBI:27569 T3	arabinogalactan
N2	CHEBI:27569 T4	arabinogalactan
N3	CHEBI:27569 T7	arabinogalactan
N4	CHEBI:26666 T8	short-chain fatty acid
N5	CHEBI:25140 T14	maltodextrin
N6	NCIT:C189550 T17	Firmicutes to Bacteroidetes Ratio Measurement
N7	NCBITAXON:976 T19	Bacteroidetes
N8	NCBITAXON:1239 T21	Firmicutes
N9	NCBITAXON:1678 T22	Bifidobacterium
N10	MESH:C022525 T33	alpha-L-rhamnosidase
N11	MESH:C044118 T34	fructan beta-fructosidase
N12	MESH:C021512 T35	levanase
N13	CHEBI:30776 T38	hexanoic acid
N14	CHEBI:17418 T39	valeric acid
N15	CHEBI:28484 T40	isovaleric acid
N16	NCIT:C94609 T42	Bowel Function
N17	NCIT:C129750 T43	Shape and Consistency of Stool
A6	Factual E2
A7	Factual E3
A8	Factual E4
A9	Factual E5
A10	Factual E6
A11	Factual E7
A12	Factual E9
A13	Factual E10
A14	Factual E11
A15	Factual E12
A16	Factual E13
A17	Factual E14
A18	Factual E15
